Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
J N Joyce, J H Meador-Woodruff

Abstract

The dopamine (DA) hypothesis of schizophrenia, which was based largely on evidence that pharmacological manipulations of DA systems influence the symptoms of schizophrenia, is undergoing a transformation due to our knowledge of the anatomy and pharmacology of additional subtypes of dopamine receptors. New research links the multiplicity of D2-like receptors to divergent neuroanatomic sites of suspected pathology in schizophrenia. We hypothesize that this research suggests that D2 receptors in the basal ganglia are the likely site of extrapyramidal symptoms and not antipsychotic effects. Rather, D3 receptors of the mesolimbic system are a likely site of antipsychotic effects, and D2 and D4 receptors in the medial temporal lobe and limbic cortical areas are the sites of additional antipsychotic effects. This work also suggests that divergent DA receptor circuits are likely associated with the pathophysiology of this disorder.

Citations

Oct 2, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·H L RyooJ N Joyce
Feb 19, 2005·Psychopharmacology·James M StoneLyn S Pilowsky
Dec 23, 2006·Archives of Sexual Behavior·Carolyn T HalpernDenise D Hallfors
Jan 23, 1999·Biological Psychiatry·L D Selemon, P S Goldman-Rakic
Aug 28, 1998·European Journal of Pharmacology·J M WilsonH H Van Tol
Oct 9, 1999·Pharmacology, Biochemistry, and Behavior·A J Goudie, J A Smith
Mar 17, 2000·Brain Research. Brain Research Reviews·L Heimer
Jul 27, 2001·Journal of Chemical Neuroanatomy·Y L HurdG C Sedvall
Nov 22, 2000·Bioorganic & Medicinal Chemistry Letters·N E AustinM Wood
May 2, 2001·Parkinsonism & Related Disorders·J N. JoyceT Beach
Oct 5, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert E McCullumsmithJames H Meador-Woodruff
Feb 9, 2007·Pharmacogenomics·Maurits E L ArbouwHenk-Jan Guchelaar
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·Z U KhanP S Goldman-Rakic
Jul 23, 1999·Annals of the New York Academy of Sciences·J N Joyce, E V Gurevich
Jan 29, 2011·Bioorganic & Medicinal Chemistry Letters·Raquel OrtegaChristian F Masaguer
Feb 17, 2009·Bioorganic & Medicinal Chemistry Letters·Raquel OrtegaFerran Sanz
Oct 9, 2007·Neuroscience and Biobehavioral Reviews·Magali Peeters, François Giuliano
Jun 22, 2010·CNS Neuroscience & Therapeutics·Robert A MitchellKrista L Lanctôt
Feb 10, 2006·Expert Review of Neurotherapeutics·James M Stone, Lyn S Pilowsky
Mar 18, 2004·Neuroimaging Clinics of North America·David ErritzoeAnissa Abi-Dargham
Dec 10, 2013·Neuropharmacology·Samantha R Cote, Eldo V Kuzhikandathil
Jan 22, 2010·Journal of Neurochemistry·Emma Perez-CostasRosalinda C Roberts
Jan 1, 2012·Biomolecules & Therapeutics·Maria D RubioJames H Meador-Woodruff
Sep 10, 2013·Bioorganic & Medicinal Chemistry Letters·Ignacio InsuaLaura Carro
May 4, 2013·Expert Opinion on Investigational Drugs·Naren P Rao, Gary Remington
Jun 2, 2015·The International Journal of Biochemistry & Cell Biology·Hannah LokeJoohyung Lee
Jul 11, 2013·Medical Hypotheses·Sérgio A Mota-Rolim, John F Araujo
Feb 17, 2009·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Clement C ZaiJames L Kennedy
Nov 7, 2016·The International Journal of Neuropsychopharmacology·Yongsheng ZhuFangyuan Yin
Oct 29, 2003·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Anissa Abi-Dargham, Holly Moore
May 21, 1999·The Australian and New Zealand Journal of Psychiatry·E Gordon
Jan 18, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Radhika Chadha, James H Meador-Woodruff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
J H Meador-WoodruffS J Watson
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
E Gurevich, J N Joyce
© 2021 Meta ULC. All rights reserved